Clinical trial
Hyperbaric Oxygen Treatment for Necrotizing Fasciitis and Necrotizing Soft Tissue Infections
NCT07170020 is registered in ClinicalTrials.gov with Corewell Health West as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hyperbaric Oxygen Treatment for Necrotizing Fasciitis and Necrotizing Soft Tissue Infections
- Lead sponsor
- Corewell Health West
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 14, 2025
- Completion date
- November 14, 2027
- Enrollment
- 160 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
necrotizing fascitis